Renovaro Biosciences Inc (RENB)

Currency in USD
0.246
+0.021(+9.33%)
Closed·
After Hours
0.245-0.001(-0.49%)
·
RENB Scorecard
Full Analysis
Suffers from weak gross profit margins
Trading near 52-week Low
RENB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2200.250
52 wk Range
0.2202.100
Key Statistics
Prev. Close
0.225
Open
0.23
Day's Range
0.22-0.25
52 wk Range
0.22-2.1
Volume
1.38M
Average Volume (3m)
3.65M
1-Year Change
-62.05%
Book Value / Share
0.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RENB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Renovaro Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Renovaro Biosciences Inc Company Profile

Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company has a strategic collaboration with Nebul to advance the early detection of cancer and other diseases. The company was formerly known as Renovaro Biosciences Inc. and changed its name to Renovaro Inc. in February 2024. Renovaro Inc. is headquartered in Los Angeles, California.

Compare RENB to Peers and Sector

Metrics to compare
RENB
Peers
Sector
Relationship
P/E Ratio
−1.0x−3.5x−0.5x
PEG Ratio
−0.010.000.00
Price/Book
0.6x2.7x2.6x
Price / LTM Sales
-150.6x3.3x
Upside (Analyst Target)
-196.4%43.5%
Fair Value Upside
Unlock6.6%6.8%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RENB Income Statement

People Also Watch

2.070
VOR
0.00%
2.56
INMB
-8.24%
18.23
SRPT
+1.50%
6.0400
UPXI
+8.44%
3.785
PRME
+2.85%

FAQ

What Stock Exchange Does Renovaro Biosciences Trade On?

Renovaro Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Renovaro Biosciences?

The stock symbol for Renovaro Biosciences is "RENB."

What Is the Renovaro Biosciences Market Cap?

As of today, Renovaro Biosciences market cap is 56.90M.

What Is Renovaro Biosciences's Earnings Per Share (TTM)?

The Renovaro Biosciences EPS (TTM) is -0.38.

From a Technical Analysis Perspective, Is RENB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Renovaro Biosciences Stock Split?

Renovaro Biosciences has split 0 times.

How Many Employees Does Renovaro Biosciences Have?

Renovaro Biosciences has 25 employees.

What is the current trading status of Renovaro Biosciences (RENB)?

As of 09 Aug 2025, Renovaro Biosciences (RENB) is trading at a price of 0.25, with a previous close of 0.23. The stock has fluctuated within a day range of 0.22 to 0.25, while its 52-week range spans from 0.22 to 2.10.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.